Celentyx Ltd.-Product Pipeline Review-2015

Celentyx Ltd.-Product Pipeline Review-2015

  • Products Id :- GMDHC06974CDB
  • |
  • Pages: 21
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Celentyx Ltd.-Product Pipeline Review-2015


Global Markets Direct's, 'Celentyx Ltd.-Product Pipeline Review-2015', provides an overview of the Celentyx Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Celentyx Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of Celentyx Ltd. including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Celentyx Ltd.'s human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Celentyx Ltd.'s pipeline products

Reasons To Buy

Evaluate Celentyx Ltd.'s strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Celentyx Ltd. in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Celentyx Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Celentyx Ltd. and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Celentyx Ltd.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Celentyx Ltd. and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Celentyx Ltd. Snapshot 4

Celentyx Ltd. Overview 4

Key Information 4

Key Facts 4

Celentyx Ltd.-Research and Development Overview 5

Key Therapeutic Areas 5

Celentyx Ltd.-Pipeline Review 7

Pipeline Products by Stage of Development 7

Pipeline Products-Monotherapy 8

Celentyx Ltd.-Pipeline Products Glance 9

Celentyx Ltd.-Clinical Stage Pipeline Products 9

Phase I Products/Combination Treatment Modalities 9

Celentyx Ltd.-Early Stage Pipeline Products 10

Discovery Products/Combination Treatment Modalities 10

Celentyx Ltd.-Drug Profiles 11

CX-1001 11

Product Description 11

Mechanism of Action 11

R&D Progress 11

CX-1010 12

Product Description 12

Mechanism of Action 12

R&D Progress 12

CX-1020 13

Product Description 13

Mechanism of Action 13

R&D Progress 13

CX-1030 14

Product Description 14

Mechanism of Action 14

R&D Progress 14

CX-1040 15

Product Description 15

Mechanism of Action 15

R&D Progress 15

Celentyx Ltd.-Pipeline Analysis 16

Celentyx Ltd.-Pipeline Products by Target 16

Celentyx Ltd.-Pipeline Products by Molecule Type 17

Celentyx Ltd.-Pipeline Products by Mechanism of Action 18

Celentyx Ltd.-Locations And Subsidiaries 19

Head Office 19

Appendix 20

Methodology 20

Coverage 20

Secondary Research 20

Primary Research 20

Expert Panel Validation 20

Contact Us 20

Disclaimer 21

List of Tables

Celentyx Ltd., Key Information 4

Celentyx Ltd., Key Facts 4

Celentyx Ltd.-Pipeline by Indication, 2015 6

Celentyx Ltd.-Pipeline by Stage of Development, 2015 7

Celentyx Ltd.-Monotherapy Products in Pipeline, 2015 8

Celentyx Ltd.-Phase I, 2015 9

Celentyx Ltd.-Discovery, 2015 10

Celentyx Ltd.-Pipeline by Target, 2015 16

Celentyx Ltd.-Pipeline by Molecule Type, 2015 17

Celentyx Ltd.-Pipeline Products by Mechanism of Action, 2015 18

List of Figures

Celentyx Ltd.-Pipeline by Top 10 Indication, 2015 6

Celentyx Ltd.-Pipeline by Stage of Development, 2015 7

Celentyx Ltd.-Monotherapy Products in Pipeline, 2015 8

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com

Current R&D Portfolio of Celentyx Ltd.; Celentyx Ltd. - Key Therapeutics; Celentyx Ltd. - Pipeline Overview and Promising Molecules; Celentyx Ltd. - News; Celentyx Ltd. - Latest Updates; Celentyx Ltd. - Pipeline; Celentyx Ltd. - Discontinued/Dormant Projects

select a license

Single User License
USD 1500 INR 97215
Site License
USD 3000 INR 194430
Corporate User License
USD 4500 INR 291645



The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...

Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

query [@] kenresearch.com